Vident Investment Advisory, LLC Instil Bio, Inc. Transaction History

Vident Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.37 $62,705 - $99,384	-13,485 Reduced 9.68%	125,869 $609,000
Q2 2022 Aug 15, 2022	BUY	$4.21 - $11.15 $295,078 - $781,503	70,090 Added 101.19%	139,354 $644,000
Q1 2022 May 16, 2022	BUY	$8.48 - $18.1 $97,901 - $208,964	11,545 Added 20.0%	69,264 $745,000
Q4 2021 Feb 14, 2022	SELL	$15.37 - $22.5 $450,264 - $659,137	-29,295 Reduced 33.67%	57,719 $988,000
Q3 2021 Nov 12, 2021	SELL	$15.05 - $23.28 $93,550 - $144,708	-6,216 Reduced 6.67%	87,014 $1.56 Million
Q2 2021 Aug 13, 2021	BUY	$15.31 - $24.63 $1.43 Million - $2.3 Million	93,230 New	93,230 $1.8 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.82B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.